Directory Industries Places KnowledgeComparisonsSoon

Sign in Check visibility

Recognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

Product

Pricing
Directory
Industries

Company

About
Contact
Legal

© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today

DirectoryBusiness & Technical ServicesResearch & DevelopmentLausanneAvrion Therapeutics SA

Verified· 3 sources

Avrion Therapeutics SA

Summary

About the company

The core activity of Avrion Tx is the development of gene therapies, particularly for the treatment of rare diseases and specific forms of blindness.

AI-generated

Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

✓ Offered3

Precision gene therapies

Precision gene therapies targeting neurological disorders, with a vector platform specific to cell types of the central nervous system and expression limited to the tissues of interest.

Gene therapy development for ALS

Development of therapeutic candidates AVR-001 and AVR-002 for amyotrophic lateral sclerosis, including preclinical studies and preparatory work for clinical trials.

Therapeutic target discovery

Preclinical target discovery platform in partnership with EPFL, using human genetics, humanized Drosophila models, machine vision, and AI-assisted phenotypic screening.

Press

Media

January 18, 2021Media

Life science start-ups attract experienced board members

startupticker.ch

Comparisons

Avrion Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Avrion Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Avrion Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Location

Rue de Bourg 27

1003 Lausanne

At a glance

Legal form: Corporation
UID: CHE-217.996.344
Founded: 2020 · 6 years
Last commercial register change: September 2, 2025
Employees: 11 to 20

Knowledge

No knowledge articles yet

Once Avrion Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Similar companies

ND BioSciences SA

Fondation ISREC, anciennement Institut suisse de recherche expérimentale sur le cancer

Jacot & Cie Electronic SNC

Lavaux Biotech Consulting Sàrl

Debiopharm International SA

Scientific Visual SA